JPH0316357B2 - - Google Patents
Info
- Publication number
- JPH0316357B2 JPH0316357B2 JP55084981A JP8498180A JPH0316357B2 JP H0316357 B2 JPH0316357 B2 JP H0316357B2 JP 55084981 A JP55084981 A JP 55084981A JP 8498180 A JP8498180 A JP 8498180A JP H0316357 B2 JPH0316357 B2 JP H0316357B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- alkoxy
- alkyl
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 phosphorous triester Chemical class 0.000 claims description 74
- 150000001875 compounds Chemical class 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 125000004442 acylamino group Chemical group 0.000 claims description 11
- 125000004423 acyloxy group Chemical group 0.000 claims description 11
- 125000004414 alkyl thio group Chemical group 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 11
- 229910052717 sulfur Inorganic materials 0.000 claims description 11
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 claims description 10
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 10
- 125000004434 sulfur atom Chemical group 0.000 claims description 10
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 7
- 125000005389 trialkylsiloxy group Chemical group 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 125000001118 alkylidene group Chemical group 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims description 4
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 3
- RLMOMHNXIWBGTF-UHFFFAOYSA-N diaminophosphinoamine Chemical compound NP(N)N RLMOMHNXIWBGTF-UHFFFAOYSA-N 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 48
- 239000002904 solvent Substances 0.000 description 30
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 238000002329 infrared spectrum Methods 0.000 description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- 239000013078 crystal Substances 0.000 description 13
- 239000008363 phosphate buffer Substances 0.000 description 13
- 239000012046 mixed solvent Substances 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 150000002961 penems Chemical class 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 11
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 238000007796 conventional method Methods 0.000 description 9
- 238000012746 preparative thin layer chromatography Methods 0.000 description 9
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 238000004440 column chromatography Methods 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 125000004149 thio group Chemical group *S* 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 229940125898 compound 5 Drugs 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 6
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- STDMSPQVWBOVAM-UHFFFAOYSA-N (4-nitrophenyl)methyl 2-chloro-2-oxoacetate Chemical compound [O-][N+](=O)C1=CC=C(COC(=O)C(Cl)=O)C=C1 STDMSPQVWBOVAM-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- VSFGCDCAYWYMSN-RXMQYKEDSA-N COC=1S[C@H]2N(C=1)C(C2)=O Chemical class COC=1S[C@H]2N(C=1)C(C2)=O VSFGCDCAYWYMSN-RXMQYKEDSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- XZTDZDWUBLOPKW-SJPGBGKRSA-N (4-nitrophenyl)methyl (5R,6S)-6-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-3-[(2R)-1-[(4-nitrophenyl)methoxycarbonylamino]propan-2-yl]sulfanyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound [Si](C)(C)(C(C)(C)C)O[C@H](C)[C@@H]1[C@@H]2N(C(=C(S2)S[C@@H](CNC(=O)OCC2=CC=C(C=C2)[N+](=O)[O-])C)C(=O)OCC2=CC=C(C=C2)[N+](=O)[O-])C1=O XZTDZDWUBLOPKW-SJPGBGKRSA-N 0.000 description 1
- NFHAMKOEKXEREX-BNAYCWRJSA-N (4-nitrophenyl)methyl (5R,6S)-6-[(1R)-1-[tert-butyl(dimethyl)silyl]oxyethyl]-3-[2-[(4-nitrophenyl)methoxycarbonylamino]ethylsulfanyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate Chemical compound [Si](C)(C)(C(C)(C)C)O[C@H](C)[C@@H]1[C@@H]2N(C(=C(S2)SCCNC(=O)OCC2=CC=C(C=C2)[N+](=O)[O-])C(=O)OCC2=CC=C(C=C2)[N+](=O)[O-])C1=O NFHAMKOEKXEREX-BNAYCWRJSA-N 0.000 description 1
- IQGCCVWSFFZMMR-ZCFIWIBFSA-N (5R)-3-methyl-4-thia-1-azabicyclo[3.2.0]hept-2-ene-7-thione Chemical class CC=1S[C@H]2N(C=1)C(C2)=S IQGCCVWSFFZMMR-ZCFIWIBFSA-N 0.000 description 1
- MNVCCKVPSGWSCN-RXMQYKEDSA-N (5r)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound S1C(C)=C(C(O)=O)N2C(=O)C[C@H]21 MNVCCKVPSGWSCN-RXMQYKEDSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000006024 2-pentenyl group Chemical group 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 244000186140 Asperula odorata Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- MACFJDNYEKKXFS-GFCCVEGCSA-N CC(S[C@@H]1C2)=C(C(OCC(C=C3)=CC=C3[N+]([O-])=O)=S)N1C2=O Chemical compound CC(S[C@@H]1C2)=C(C(OCC(C=C3)=CC=C3[N+]([O-])=O)=S)N1C2=O MACFJDNYEKKXFS-GFCCVEGCSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 235000008526 Galium odoratum Nutrition 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N Glyoxylic acid Natural products OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000005042 acyloxymethyl group Chemical group 0.000 description 1
- 125000005035 acylthio group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000004849 alkoxymethyl group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- MEVHTHLQPUQANE-UHFFFAOYSA-N aziridine-2,3-dione Chemical compound O=C1NC1=O MEVHTHLQPUQANE-UHFFFAOYSA-N 0.000 description 1
- OWAQXCQNWNJICI-UHFFFAOYSA-N benzene;chloroform Chemical compound ClC(Cl)Cl.C1=CC=CC=C1 OWAQXCQNWNJICI-UHFFFAOYSA-N 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000006244 carboxylic acid protecting group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- SKCNIGRBPJIUBQ-UHFFFAOYSA-N chloroform;ethyl acetate Chemical compound ClC(Cl)Cl.CCOC(C)=O SKCNIGRBPJIUBQ-UHFFFAOYSA-N 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 229950003188 isovaleryl diethylamide Drugs 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- ZXUQEPZWVQIOJE-UHFFFAOYSA-N methyl 2-chloro-2-oxoacetate Chemical compound COC(=O)C(Cl)=O ZXUQEPZWVQIOJE-UHFFFAOYSA-N 0.000 description 1
- XVDBWWRIXBMVJV-UHFFFAOYSA-N n-[bis(dimethylamino)phosphanyl]-n-methylmethanamine Chemical compound CN(C)P(N(C)C)N(C)C XVDBWWRIXBMVJV-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 150000008301 phosphite esters Chemical class 0.000 description 1
- 125000005633 phthalidyl group Chemical group 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- AAZYNPCMLRQUHI-UHFFFAOYSA-N propan-2-one;2-propan-2-yloxypropane Chemical compound CC(C)=O.CC(C)OC(C)C AAZYNPCMLRQUHI-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- NYOUQWVIMBQOJL-UHFFFAOYSA-N s-(4-oxoazetidin-2-yl) ethanethioate Chemical compound CC(=O)SC1CC(=O)N1 NYOUQWVIMBQOJL-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、一般式
を有するペネム−3−カルボン酸誘導体を製造す
る方法に関するものである。
上記式()中、R1は水素原子、アルキル基
またはR4A−基(式中、R4は水酸基、アルコキ
シ基、アシルオキシ基、トリアルキルシリルオキ
シ基、アルキルチオ基またはアシルアミノ基を示
し、Aはトリフルオロメチルで置換されてもよい
アルキリデン基を示す。)を表わし、R2はアルキ
ル基、アルケニル基、アラルキル基、アリール基
またはR5−B−基(式中、R5は水酸基、アルコ
キシ基、アシルオキシ基、トリアルキルシリルオ
キシ基、カルボキシル基、アルコキシカルボニル
基、アラルキルオキシカルボニル基、アルキルチ
オ基またはアシルアミノ基を示し、Bはアルキレ
ン基を示す。)を表わし、R3はカルボキシル基の
保護基を表わし、Yは酸素原子、硫黄原子あるい
はメチレン基若しくはアルキル置換メチレン基を
表わし、またR2−Y−基はメチル基を表わして
もよい。
前記一般式()において、R1は好適には水
素原子、例えばメチル、エチル、n−プロピル、
イソプロピル、n−ブチル、イソブチル、sec−
ブチル、tert−ブチル、n−ペンチル、イソペン
チルのような直鎖状若しくは分枝鎖状の低級アル
キル基またはR4A−基(式中、R4は水酸基、例
えばメトキシ、エトキシ、n−プロポキシ、イソ
プロポキシのような低級アルコキシ基、例えばア
セトキシ、プロピオニルオキシ、n−ブチリルオ
キシ、イソブチリルオキシのような低級脂肪族ア
シルオキシ基若しくはベンジルオキシカルボニル
オキシ、p−ニトロベンジルオキシカルボニルオ
キシ、o−ニトロベンジルオキシカルボニルオキ
シのようなアラルキルオキシカルボニルオキシ基
などのアシルオキシ基、例えばtert−ブチルジメ
チルシリルオキシのようなトリ低級アルキルシリ
ルオキシ基、例えばメチルチオ、エチルチオ、n
−プロピルチオ、イソプロピルチオのような低級
アルキルチオ基、例えばアセチルアミノ、プロピ
オニルアミノ、n−ブチリルアミノ、イソブチリ
ルアミノのような低級脂肪族アシルアミノ基若し
くはベンジルオキシカルボニルアミノ、p−ニト
ロベンジルオキシカルボニルアミノ、o−ニトロ
ベンジルオキシカルボニルアミノのようなアラル
キルオキシカルボニルアミノ基などのアシルアミ
ノ基を示し、Aはメチレン、エチリデン、プロピ
リデン、ブチリデン、ベンチリデン、2,2,2
−トリフルオロエチリデン、3,3,3−トリフ
ルオロプロピリデンのようなトリフルオロメチル
基で置換されてもよいアルキリデン基を示す。)
であり、R2は好適には例えばメチル、エチル、
n−プロピル、イソプロピル、n−ブチル、イソ
ブチル、sec−ブチル、tert−ブチル、n−ペン
チル、イソペンチルのような直鎖状若しくは分枝
鎖状の低級アルキル基、例えばアリル、2−ブテ
ニル、3−メチル−2−ブテニル、2−ペンテニ
ルのような直鎖状若しくは分枝鎖状の低級アルケ
ニル基、例えば芳香環にメチル、エチル、n−プ
ロピル、イソプロピルのような低級アルキル基、
メトキシ、エトキシ、n−プロポキシ、イソプロ
ポキシのような低級アルコキシ基若しくはフツ
素、塩素、臭素のようなハロゲン原子を置換分と
して有するか有しないベンジル、フエネチル、フ
エニルプロピルのようなアラルキル基、例えば芳
香環にメチル、エチル、n−プロピル、イソプロ
ピルのような低級アルキル基、メトキシ、エトキ
シ、n−プロポキシ、イソプロポキシのような低
級アルコキシ基若しくはフツ素、塩素、臭素のよ
うなハロゲン原子を置換分として有するか有しな
いフエニルのようなアリール基またはR5B−基
(式中、R5は水酸基、例えばメトキシ、エトキ
シ、n−プロポキシ、イソプロポキシのような低
級アルコキシ基、例えばアセトキシ、プロピオニ
ルオキシ、n−ブチリルオキシ、イソブチリルオ
キシのような低級脂肪族アシルオキシ基、メトキ
サリルオキシ、エトキサリルオキシ、n−プロポ
キサリルオキシのような低級アルコキシオキサリ
ルオキシ基若しくはベンジルオキシカルボニルオ
キシ、p−ニトロベンジルオキシカルボニルオキ
シのようなアラルキルオキシカルボニルオキシ基
などのアシルオキシ基、例えばtert−ブチルジメ
チルシリルオキシのような低級アルキルシリルオ
キシ基、カルボキシル基、例えばメトキシカルボ
ニル、エトキシカルボニル、n−プロポキシカル
ボニル、イソプロポキシカルボニルのような低級
アルコキシカルボニル基、例えばベンジルオキシ
カルボニル、p−ニトロベンジルオキシカルボニ
ルのようなアラルキルオキシカルボニル基、例え
ばメチルチオ、エチルチオ、n−プロピルチオ、
イソプロピルチオのような低級アルキルチオ基、
例えばアセチルアミノ、プロピオニルアミノ、n
−ブチリルアミノ、イソブチリルアミノのような
低級脂肪族アシルアミノ基、若しくは例えばベン
ジルオキシカルボニルアミノ、p−ニトロベンジ
ルオキシカルボニルアミノ、o−ニトロベンジル
オキシカルボニルアミノのようなアラルキルオキ
シカルボニルアミノ基などのアシルアミノ基を示
し、Bは例えばメチレン、エチレン、トリメチレ
ン、プロピレン、テトラメチレン、ペンタメチレ
ンのような直鎖状若しくは分枝鎖状の低級アルキ
レン基を示す。)であり、R3は好適には例えばメ
チル、エチル、n−プロピル、イソプロピル、n
−ブチル、イソブチル、tert−ブチルのような直
鎖状若しくは分枝鎖状の低級アルキル基、例えば
メトキシメチル、エトキシメチル、n−プロポキ
シメチル、イソプロポキシメチル、n−ブトキシ
メチル、イソブトキシメチルのような低級アルコ
キシメチル基、例えばアセトキシメチル、プロピ
オニルオキシメチル、n−ブチリルオキシメチ
ル、イソブチリルオキシメチル、ピバロイルオキ
シメチルのような低級脂肪族アシルオキシメチル
基、例えば1−メトキシカルボニルオキシエチ
ル、1−エトキシカルボニルオキシエチル、1−
n−プロポキシカルボニルオキシエチル、1−イ
ソプロポキシカルボニルオキシエチル、1−n−
ブトキシカルボニルオキシエチル、1−イソブト
キシカルボニルオキシエチルのような1−低級ア
ルコキシカルボニルオキシエチル基、例えばベン
ジル、p−メトキシベンジル、o−ニトロベンジ
ル、p−ニトロベンジル基またはフタリジル基で
あり、Yは酸素原子、硫黄原子あるいはメチル、
エチル、n−プロピル、イソプロピルのような低
級アルキル基で置換されていてもよいメチレン基
であり、またR2Y−基はメチル基を表わしてもよ
い。
なお、前記一般式()を有する化合物におい
ては不斉炭素原子に基く光学異性体および立体異
性体が存在し、これらの異性体がすべて単一の式
で示されているが、これによつて本発明の記載の
範囲は限定されるものではない。しかしながら、
好適には5位の炭素原子がペニシリン類と同一配
位すなわちR配位を有する化合物を選択すること
ができる。
本発明にふくまれる製造法に関して、以下に詳
しく説明する。
出発原料は一般式
(式中、R1,R2,R3およびYは前述したもの
と同意義を示し、Xは酸素原子または硫黄原子を
示す。)
を有する化合物であり、好適には
The present invention is based on the general formula The present invention relates to a method for producing a penem-3-carboxylic acid derivative having the following. In the above formula (), R 1 is a hydrogen atom, an alkyl group, or an R 4 A- group (wherein R 4 represents a hydroxyl group, an alkoxy group, an acyloxy group, a trialkylsilyloxy group, an alkylthio group, or an acylamino group, and represents an alkylidene group which may be substituted with trifluoromethyl), and R 2 represents an alkyl group, an alkenyl group, an aralkyl group, an aryl group, or an R 5 -B- group (wherein R 5 represents a hydroxyl group, an alkoxy (B represents an alkylene group), and R 3 represents a carboxyl group-protecting group. , Y represents an oxygen atom, a sulfur atom, a methylene group or an alkyl-substituted methylene group, and the R 2 -Y- group may represent a methyl group. In the general formula (), R 1 is preferably a hydrogen atom, such as methyl, ethyl, n-propyl,
Isopropyl, n-butyl, isobutyl, sec-
A linear or branched lower alkyl group such as butyl, tert-butyl, n-pentyl, isopentyl, or an R 4 A- group (wherein R 4 is a hydroxyl group, such as methoxy, ethoxy, n-propoxy, Lower alkoxy groups such as isopropoxy, lower aliphatic acyloxy groups such as acetoxy, propionyloxy, n-butyryloxy, isobutyryloxy or benzyloxycarbonyloxy, p-nitrobenzyloxycarbonyloxy, o-nitrobenzyloxy Acyloxy groups such as aralkyloxycarbonyloxy groups such as carbonyloxy, tri-lower alkylsilyloxy groups such as tert-butyldimethylsilyloxy, e.g. methylthio, ethylthio, n
- lower alkylthio groups such as propylthio, isopropylthio, lower aliphatic acylamino groups such as acetylamino, propionylamino, n-butyrylamino, isobutyrylamino or benzyloxycarbonylamino, p-nitrobenzyloxycarbonylamino, o - indicates an acylamino group such as an aralkyloxycarbonylamino group such as nitrobenzyloxycarbonylamino, A is methylene, ethylidene, propylidene, butylidene, bentylidene, 2,2,2
- indicates an alkylidene group which may be substituted with a trifluoromethyl group such as trifluoroethylidene and 3,3,3-trifluoropropylidene. )
and R 2 is preferably, for example, methyl, ethyl,
Straight-chain or branched lower alkyl groups such as n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, such as allyl, 2-butenyl, 3- Straight-chain or branched lower alkenyl groups such as methyl-2-butenyl and 2-pentenyl; for example, lower alkyl groups such as methyl, ethyl, n-propyl, and isopropyl in an aromatic ring;
Lower alkoxy groups such as methoxy, ethoxy, n-propoxy, isopropoxy or aralkyl groups such as benzyl, phenethyl, phenylpropyl with or without substituents such as halogen atoms such as fluorine, chlorine and bromine, e.g. Aromatic rings are substituted with lower alkyl groups such as methyl, ethyl, n-propyl, and isopropyl, lower alkoxy groups such as methoxy, ethoxy, n-propoxy, and isopropoxy, or halogen atoms such as fluorine, chlorine, and bromine. an aryl group such as phenyl or an R 5 B- group with or without the presence of a hydroxyl group, e.g. a lower alkoxy group such as methoxy , ethoxy, n-propoxy, isopropoxy, e.g. acetoxy, propionyloxy, Lower aliphatic acyloxy groups such as n-butyryloxy and isobutyryloxy, lower alkoxyoxalyloxy groups such as methoxalyloxy, ethoxalyloxy, and n-propoxalyloxy, or benzyloxycarbonyloxy and p-nitrobenzyloxy Acyloxy groups such as aralkyloxycarbonyloxy groups such as carbonyloxy, lower alkylsilyloxy groups such as tert-butyldimethylsilyloxy, carboxyl groups such as methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl; lower alkoxycarbonyl groups such as benzyloxycarbonyl, aralkyloxycarbonyl groups such as p-nitrobenzyloxycarbonyl, such as methylthio, ethylthio, n-propylthio,
lower alkylthio groups such as isopropylthio,
For example, acetylamino, propionylamino, n
- lower aliphatic acylamino groups such as butyrylamino, isobutyrylamino, or acylamino groups such as aralkyloxycarbonylamino groups such as benzyloxycarbonylamino, p-nitrobenzyloxycarbonylamino, o-nitrobenzyloxycarbonylamino; and B represents a linear or branched lower alkylene group such as methylene, ethylene, trimethylene, propylene, tetramethylene, and pentamethylene. ), and R 3 is preferably, for example, methyl, ethyl, n-propyl, isopropyl, n
- straight-chain or branched lower alkyl groups such as butyl, isobutyl, tert-butyl, such as methoxymethyl, ethoxymethyl, n-propoxymethyl, isopropoxymethyl, n-butoxymethyl, isobutoxymethyl; lower alkoxymethyl groups such as acetoxymethyl, propionyloxymethyl, n-butyryloxymethyl, isobutyryloxymethyl, lower aliphatic acyloxymethyl groups such as pivaloyloxymethyl, such as 1-methoxycarbonyloxyethyl, 1-ethoxycarbonyloxyethyl, 1-
n-propoxycarbonyloxyethyl, 1-isopropoxycarbonyloxyethyl, 1-n-
a 1-lower alkoxycarbonyloxyethyl group such as butoxycarbonyloxyethyl, 1-isobutoxycarbonyloxyethyl, for example a benzyl, p-methoxybenzyl, o-nitrobenzyl, p-nitrobenzyl group or a phthalidyl group, and Y is oxygen atom, sulfur atom or methyl,
It is a methylene group which may be substituted with a lower alkyl group such as ethyl, n-propyl or isopropyl, and the R 2 Y- group may represent a methyl group. In addition, in the compound having the above general formula (), there are optical isomers and stereoisomers based on asymmetric carbon atoms, and all of these isomers are shown by a single formula, but by this, The scope of the description of the present invention is not limited. however,
Preferably, a compound can be selected in which the carbon atom at the 5th position has the same coordination as that of penicillins, that is, the R coordination. The manufacturing method included in the present invention will be explained in detail below. Starting materials are general formula (In the formula, R 1 , R 2 , R 3 and Y have the same meanings as described above, and X represents an oxygen atom or a sulfur atom.)
【式】
と合一して表現する場合、X=S,=Sのような
〔(アルキル)チオ〕チオカルボニル〕チオ基、X
=S,Y=Oのような〔(アルコキシ)チオカル
ボニル〕チオ基、X=S,Y=CH2−のような
〔(アルキル)チオカルボニル〕チオ基、X=O,
Y=Sのような〔(アルキルチオ)カルボニル〕
チオ基X=O,Y=Oのような(アルコキシカル
ボニル)チオ基、X=O,Y=CH2−のようなア
シルチオ基で示され、これらの化合物は文献〔S.
Oida,A.Yoshida,T.Hayashi,N.Takeda,T.
Nishimura and E.Ohki,J.Antibiotics33,107
(1980);I.Ernest,J.Gosteli,C.W.Greengrass,
W.Holick,D.E.Jackman,H.R.Pfaendler,and
R.B.Woodward,J.Am.chem.Soc.,100,8214
(1978)〕
の方法にしたがつて合成して得られる一般式
(式中、R1,R2,XおよびYは前述したもの
と同意義を示す。)
で表されるアゼチジノン誘導体を参考例に記す如
く溶剤中1乃至4当量のトリエチルアミンのよう
な有機塩基の存在下、1乃至4当量の一般式
XCOCOOR3 ()
(式中、Xは塩素原子または臭素原子のような
ハロゲン原子を示し、R3は前述したものと同意
義を示す。)
で表わされるアルコキサリルハライドと反応せし
めて準備することができる。
本発明の方法における反応は、上述の原料すな
わち一般式()であらわされるアゼチジノン誘
導体を溶媒の存在下、2乃至20当量の一般式
(R4)3P ()
(式中、R4はアルコキシ基またはジアルキル
アミノ基を表わす。)
で表わされる亜リン酸トリメチル若しくは亜リン
酸トリエチル等の亜リン酸エステルあるいはトリ
ス(ジメチルアミノ)フオスフイン等の亜リン酸
アミドと接触せしめる事により、一般式()で
表わされるペネム−3−カルボン酸誘導体を製造
するものである。
本反応を実施するにあたつて、使用される溶剤
としては本反応に関与しないものであれば特に限
定はないが、メタノール、エタノール、プロパノ
ール、イソプロパノール等のアルコール類、テト
ラヒドロフラン、ジオキサン等のエーテル類、酢
酸エチルエステル、酢酸ブチルエステル等のエス
テル類、ベンゼン、トルエンのような芳香族炭化
水素、クロロホルム、メチレンクロリドのような
ハロゲン化炭化水素、ジメチルホルムアミド、ジ
メチルアセトアミドのようなジアルキル脂肪酸ア
ミド、アセトニトリルのようなニトリル類並びに
これらの有機溶剤の混合溶剤が好適である。反応
温度は特に限定はなく通常は室温乃至150℃付近
で行なうことができるが、好適には50゜乃至150℃
付近で加熱して行なう。反応に要する時間は主に
原料の種類および反応温度により異なるが、約5
時間乃至4日間である。
反応終了後、本工程の目的化合物()は常法
に従つて反応混合物から採取される。例えば反応
混合物を必要ならば不溶物を別して後、水洗、
乾燥し溶剤および過剰の試薬を留去することによ
つて得ることができる。
このようにして得られた目的化合物は、必要な
らば常法、例えば再結晶法、分取用薄層クロマト
グラフイー、カラムクロマトグラフイーなどによ
つてさらに精製することができる。
本反応において原料化合物()を前記一般式
()で表わされる亜リン酸トリアルキルあるい
は亜リン酸トリアミドと溶剤中で室温乃至90℃ぐ
らいの比較的低温で接触せしめる場合、一般式
(式中、R1,R2,R3,R4,XおよびYは前述
したものと同意義を示す。)
で表わされるイリド化合物を得ることができる
が、これをそのまゝ精製することなく加熱処理し
て目的のペネム−3−カルボン酸誘導体()に
みちびく方法も含まれるものである。この場合の
加熱温度は100乃至150℃であり、反応時間は約4
時間乃至48時間である。
本発明によつて得られる一般式()を有する
化合物は、ペニシリンの2位と3位に二重結合を
有するペネム誘導体に属し、その2位に各種置換
アルキル基、アルキルチオあるいはアルキルオキ
シ基を有する化合物の一群であり、一般式()
中に示されたR1およびR2にふくまれる水酸基お
よびアミノ基の保護基並びにカルボン酸保護基
R3を既知の方法により除去することによつて、
例えば特願昭54−44050号に記載されているよう
な優れた抗菌活性を有する医薬として有用なペネ
ム−3−カルボン酸類にみちびくことができる重
要合成中間体である。
本発明は従来のペネム誘導体の製法に比較して
次の点で優れている。
ペネム誘導体の製法として下記の反応式で示さ
れる方法(特開昭52−71460、特開昭53−137951
および特開昭54−119486号公報)が知られてい
る。
式中、XおよびYは酸素もしくは硫黄原子また
はメチレン基を示す。
すなわちアゼチジノン誘導体1にグリオキシル
酸エステルを反応させ付加物2とし、これをチオ
ニルクロライドでハロゲン化しクロル体3とし、
化合物3を塩基の存在下トリフエニルホスインと
反応させ4とし、ついで化合物4を加熱するとペ
ネム誘導体5が得られる。
この方法では2から4は一つの反応容器内で連
続して反応させることができるので1工程と考え
られ、化合物1から3工程でペネム誘導体5が得
られます。
これに対して、本発明のペネム誘導体の製法
は、下記の反応式に従つて合成する方法である。
すなわちアゼチジノン誘導体1をオキサリル化
してオキサルイミド体6とし、化合物6とホスフ
アイト誘導体(P(OR4)3)とを反応させ化合物
7とした後、7を加熱するとペネム誘導体5が得
られる。この方法では化合物7を単離する必要が
ないので化合物1から2工程でペネム誘導体5が
得られる。また本方法により化合物1から好収率
でペネム誘導体5が得られる。
このように従来法が化合物1から3工程で化合
物5を得ることができるのに対して、本発明の製
法が化合物1から2工程で化合物5を得ることが
できる。従つて本製法は従来法に比較して優れた
ペネム誘導体の製法である。
なお本発明の製法では、80℃で加熱しても化合
物7から化合物5が得られるのに対して、化合物
4は100℃に加熱してもほとんど化合物5が得ら
れず、120℃位に加熱すると化合物5が得られる。
一般に化学反応では低温のほうが副生成物が少な
いと考えられるので、この点からも本発明の製法
が、従来法に比較し優れている。
また本方法は従来法に比較して反応時間が短
い。すなわち本方法では1から5を得るための反
応時間はおよそ5時間であるのに対し、従来法で
は3から4を得るのに必要な反応時間が約40時間
であり、4から5を得るための反応時間が約15時
間である。従つて本方法のほうが従来法よりペネ
ム誘導体の実生産方法として優れている。
実施例 1
2−メチルペネム−3−カルボン酸メチルエス
テル
N−メトキサリル−4−アセチルチオアゼチジ
ン−2−オン40mg(0.17mmol)と亜リン酸トリ
メチル65mg(0.52mmol)のジオキサン1ml溶液
を、窒素気流中95℃で15時間加熱した後、さらに
2.5時間加熱還流する。溶剤留去後の残留物を分
取用薄層クロマトグラフイー〔展開溶剤:ベンゼ
ン−酢酸エチル(5:1)〕で分離精製し、8mg
(収率23%)の目的物を結晶として得る。ヘキサ
ン−酢酸エチル混合溶剤で再結晶すると、融点
79.5〜80℃の針状晶を与える。
元素分析値 C8H9NO3Sとして
計算値:C,48.22;H,4.55;N,7.03;
S,16.09
実測値:C,48.40;H,4.59;N,6.99;
S,16.08
IRスペクトル νNujol naxcm-1:
1768,1707,1581
NMRスペクトル(CDCl3)δppm:
2.30(3H,s)、3.36(1H,dd,J=172Hz)、
3.75(1H,dd,J=12,4Hz)、3.77(3H,s)、
5.68(1H,dd,J=4,2Hz)
実施例 2
2−メチルペネム−3−カルボン酸p−ニトロ
ペンジルエステル
N−p−ニトロベンジルオキシオキサリル−4
−アセチルチオアゼチジン−2−オン84mg
(0.24mmol)と亜リン酸トリメチル238mg
(1.92mmol)の酢酸エチル11ml溶液を窒素気流下
65℃で24時間撹拌し溶剤及び揮発性物質を60℃で
減圧下留去すると、粗製4−アセチルチオ−1−
〔1−(p−ニトロベンジルオキシカルボニル)ト
リメトキシホスホラニリデンメチル〕アゼチジン
−2−オン112mgが得られる。かくして得られた
ホスホラン112mgに触媒量のp−ハイドロキノン
を加えてキシレン10mlに溶解し、窒素気流下21時
間にわたつて105℃に加熱する。溶剤留去した後
の残留物を分取用薄層クロマトグラフイー〔展開
溶剤:酢酸エチル−ベンゼン(1:8)〕で分離
精製し37mg(48%)の目的物を得る。塩化メチレ
ン−エーテルより再結晶すると、融点132〜135℃
の針状晶が得られる。本品はWoodwardら
〔Woodwardet al,J.Am.Chem.Soc.1016296
(1979)〕によつて合成された化合物(融点130〜
132℃)とIRスペクトル、NMRスペクトルが一
致する。
実施例 3
(5R,6S)−2−(2−p−ニトロベンジルオ
キシカルボニルアミノエチル)−6−〔(R)−1
−tert−ブチルジメチルシリルオキシエチル〕
ペネム−3−カルボン酸p−ニトロベンジルエ
ステル
(3S,4R)−N−p−ニトワベンジルオキシオ
キサリル−4−(3−p−ニトロベンジルオキシ
カルボニルアミノプロピオニルチオ)−3−〔(R)
−1−tert−ブチルジメチルシリルオキシエチ
ル〕アゼチジン−2−オン130mg(0.18mmol)と
亜リン酸トリメチル180mg(1.45mmol)の酢酸エ
チル17ml溶液を窒素気流下65℃で26時間撹拌し、
溶剤及び揮発性物質を60℃で減圧下留去して、粗
製(3S,4R)−4−(3−p−ニトロベンジルオ
キシカルボニルアミノプロピオニルチオ)−3−
〔(R)−1−tert−ブチルジメチルシリルオキシ
エチル〕−1−〔1−(p−ニトロベンジルオキシ
カルボニル)トリメトキシホスホラニリデンメチ
ル〕アゼチジン−2−オン155mgを得る。これに
触媒量のp−ハイドロキノンを加え、キシレン15
ml中、窒素気流下で24時間にわたつて105℃で加
熱する。溶剤に留去した後、残留物を分取用薄層
クロマトグラフイー〔展開溶剤:ベンゼン−酢酸
エチル(1:1)混合溶剤〕で分離精製し、目的
物43mg(収率35%)を油状物質として得る。
IRスペクトル νliq naxcm-1:
3400,1797,1700〜1740
NMRスペクトル(CDCl3)δppm:
0.05(3H,s)、0.08(3H,s)、0.80(9H,s)、
1.16(3H,d,J=6.5Hz)、2.8〜3.5(4H,m)、
3.70(1H,dd,J=4,1.5Hz)、4.20(1H,
m)、5.18(2H,s)、5.14(1H,d,J=15
Hz)、5.38(1H,d,J=15Hz)、5.60(1H,d,
J=1.5Hz)、7.3〜8.4(8H)
実施例 4
2−ブチルチオペネム−3−カルボン酸p−ニ
トロベンジルエステル
N−メトキサリル−4−〔(ブチルチオ)チオカ
ルボニル〕チオアゼチジン−2−オン171mg
(0.53mmol)と亜リン酸トリメチル132mg
(1.06mmol)のアセトニトリル3.5ml溶液を窒素
気流中55℃で16.5時間撹拌する。溶剤留去後の残
留物を分取用薄層クロマトグラフイー〔展開溶
剤:ベンゼン−酢酸エチル(10:1)〕で分離精
製し、39mg(収率27%)の目的物を結晶として得
る。エタノールから再結晶すると、融点100〜
101.5℃の板状晶を与える。
元素分析値 C11H15NO3S2として
計算値:C,48.32;H,5.53;N,5.12
分析値:C,48.14;H,5.52;N,5.03
IRスペクトル νNujol naxcm-1;
1769,1702
NMRスペクトル(CDCl3)δppm:
0.96(3H,t−様)、〜1.6(4H,m)、2.99(2H,
t,J=7Hz)、3.49(1H,dd,J=17,2
Hz)、3.84(3H,s)、3.86(1H,dd,J=17,
4Hz)、5.74(1H,dd,J=4,2Hz)
実施例 5
2−ブチルチオペネム−3−カルボン酸p−ニ
トロベンジルエステル
N−p−ニトロベンジルオキシオキサリル−4
−〔(ブチルチオ)チオカルボニル〕チオアゼチジ
ン−2−オン116mg(0.26mmol)と亜リン酸トリ
メチル260mg(2.10mmol)の酢酸エチル14ml溶液
を窒素気流下70℃で22時間撹拌する。溶剤を留去
した後の残留物131mgをシリカゲル6gを用いる
カラムクロマトグラフイーに付し、ベンゼン−酢
酸エチル(20:1〜10:1)で溶出される部分よ
り融点128〜129℃を有する目的物36mg(収率35
%)を結晶として得る。
本品は特願昭53−81658号(特開昭55−9034号)
に記載されている4−〔(ブチルチオ)チオカルボ
ニル〕チオ−1−〔1−(p−ニトロベンジルオキ
シカルボニル)トリフエニルホスホラニリデンメ
チル〕アゼチジン−2−オンの分子内ウイツテイ
ヒ反応により得られる化合物と融点、赤外線吸収
スペクトラム、核磁気共鳴スペクトラムが一致す
る。
IRスペクトル νnujol naxcm-1;
1786,1677
nmrスペクトル(CDCl3)δppm;
0.93(3H,t,J=6Hz)、2.98(2H,t,J=
7Hz)、3.50(1H,dd,J=17,2Hz)、3.91
(1H,dd,J=17,3.5Hz)、5.26(1H,d,J
=14Hz)、5.55(1H,d,J=14Hz)、5.77(1H,
dd,J=3.5,2Hz)、7.70(2H,d)、8.32
(2H,d)
実施例 6
(5R,6S)−2−〔〔2−(p−ニトロベンジル
オキシカルボニルアミノ)エチル〕チオ〕−6
−〔(R)−1−tert−ブチルジメチルシリルオ
キシエチル〕ペネム−3−カルボン酸p−ニト
ロベンジルエステル
(3S,4R)−N−p−ニトロベンジルオキシオ
キサリル−3−〔(R)−1−tert−ブチルジメチ
ルシリルオキシエチル〕−4−〔〔〔2−(p−ニト
ロベンジルオキシカルボニルアミノ)エチル〕チ
オ〕チオカルボニル〕チオアゼチジン−2−オン
71mg(0.093mmol)と亜リン酸トリメチル92mg
(0.74mmol)のトルエン9ml溶液を窒素気流中、
65〜75℃で34時間加熱撹拌する。溶剤留去後の残
留物を分取用薄層クロマトグラフイー(展開溶
剤:クロロホルム−酢酸エチル(5:1)で分離
精製し、31mg(47%)の目的物を油状物質として
得る。本品は特願昭54−44050号に記載されてい
る化合物とIR、NMRスペクトルが一致する。
IRスペクトル νnujol naxcm-1:
1780,1710,1670
nmrスペクトル(CDCl3)δppm:
0.03(3H,s)、0.07(3H,s)、0.80(9H,s)、
1.20(3H,d,J=6Hz)、3.04(2H,m)、
3.38(2H,t,J=5Hz)、3.66(1H,dd,J=
4,2Hz)、4.12(1H,m)、5.04(1H,d,J
=14Hz)、5.10(2H,s)、5.37(1H,d,J=
14Hz)、5.57(1H,d,J=2Hz)、7.38(2H,
d,J=9Hz)、7.50(2H,d,J=9Hz)、
8.58(4H,d,J=9Hz)
実施例 7
2−メチルチオペネム−3−カルボン酸p−ニ
トロベンジルエステル及び2−メトキシペネム
−3−カルボン酸p−ニトロベンジルエステルWhen expressed in combination with [Formula], a [(alkyl)thio]thiocarbonyl]thio group such as X=S,=S,
=S, [(alkoxy)thiocarbonyl]thio group such as Y=O, [(alkyl)thiocarbonyl]thio group such as X=S, Y=CH 2 -, X=O,
[(alkylthio)carbonyl] like Y=S
The thio group is represented by an (alkoxycarbonyl)thio group such as X=O, Y=O, or an acylthio group such as X=O, Y=CH 2 -, and these compounds are described in the literature [S.
Oida, A. Yoshida, T. Hayashi, N. Takeda, T.
Nishimura and E. Ohki, J. Antibiotics 33 , 107
(1980); I.Ernest, J.Gosteli, C.W.Greengrass,
W.Holick, DEJackman, HRPfaendler, and
R.B.Woodward, J.Am.chem.Soc., 100 , 8214
(1978)] General formula obtained by synthesis according to the method of (In the formula, R 1 , R 2 , In the presence, 1 to 4 equivalents of an alco represented by the general formula XCOCOOR 3 ( ) (wherein, It can be prepared by reacting with xalyl halide. In the reaction in the method of the present invention, the above-mentioned raw material, that is, the azetidinone derivative represented by the general formula ( or a dialkylamino group), or a phosphite ester such as trimethyl phosphite or triethyl phosphite, or a phosphite amide such as tris(dimethylamino)phosphine. This method produces a penem-3-carboxylic acid derivative represented by: In carrying out this reaction, the solvent to be used is not particularly limited as long as it does not participate in this reaction, but alcohols such as methanol, ethanol, propanol, and isopropanol, and ethers such as tetrahydrofuran and dioxane are used. , esters such as ethyl acetate and butyl acetate, aromatic hydrocarbons such as benzene and toluene, halogenated hydrocarbons such as chloroform and methylene chloride, dialkyl fatty acid amides such as dimethylformamide and dimethylacetamide, and acetonitrile. Nitriles such as these and mixed solvents of these organic solvents are suitable. The reaction temperature is not particularly limited and can usually be carried out at room temperature to around 150°C, but preferably 50° to 150°C.
Heat it nearby. The time required for the reaction varies mainly depending on the type of raw materials and reaction temperature, but it is approximately 5
The duration ranges from hours to 4 days. After the reaction is completed, the target compound () of this step is collected from the reaction mixture according to a conventional method. For example, after removing insoluble matter from the reaction mixture if necessary, washing with water,
It can be obtained by drying and distilling off the solvent and excess reagent. The target compound thus obtained can be further purified, if necessary, by conventional methods such as recrystallization, preparative thin layer chromatography, column chromatography, etc. In this reaction, when the starting compound () is brought into contact with the trialkyl phosphite or triamide phosphite represented by the above general formula () in a solvent at a relatively low temperature from room temperature to about 90°C, the general formula (In the formula, R 1 , R 2 , R 3 , R 4 , X and Y have the same meanings as described above.) A ylide compound represented by the formula can be obtained, but it is not possible to purify it as it is. This also includes a method in which the desired penem-3-carboxylic acid derivative (2) is obtained by heat treatment without heating. The heating temperature in this case is 100 to 150℃, and the reaction time is about 4
hours to 48 hours. The compound having the general formula () obtained by the present invention belongs to penem derivatives having double bonds at the 2- and 3-positions of penicillin, and has various substituted alkyl groups, alkylthio, or alkyloxy groups at the 2-position. A group of compounds, with the general formula ()
Protecting groups for hydroxyl and amino groups and carboxylic acid protecting groups contained in R 1 and R 2 shown in
By removing R 3 by known methods,
For example, it is an important synthetic intermediate that can lead to penem-3-carboxylic acids which are useful as pharmaceuticals and have excellent antibacterial activity as described in Japanese Patent Application No. 54-44050. The present invention is superior to conventional methods for producing penem derivatives in the following points. As a method for producing penem derivatives, the method shown in the following reaction formula (JP-A-52-71460, JP-A-53-137951
and Japanese Unexamined Patent Publication No. 119486/1986) are known. In the formula, X and Y represent an oxygen or sulfur atom or a methylene group. That is, azetidinone derivative 1 is reacted with glyoxylic acid ester to form adduct 2, which is halogenated with thionyl chloride to form chloride 3,
Compound 3 is reacted with triphenylphosine in the presence of a base to give 4, followed by heating of compound 4 to give the penem derivative 5. In this method, compounds 2 to 4 can be reacted continuously in one reaction vessel, so it can be considered as one step, and penem derivative 5 can be obtained from compounds 1 to 3 steps. On the other hand, the method for producing penem derivatives of the present invention is a method of synthesizing according to the following reaction formula. That is, azetidinone derivative 1 is oxalylated to form oxalimide 6, compound 6 is reacted with a phosphite derivative (P(OR 4 ) 3 ) to form compound 7, and 7 is heated to obtain penem derivative 5. In this method, there is no need to isolate compound 7, so penem derivative 5 can be obtained from compound 1 in two steps. Furthermore, by this method, penem derivative 5 can be obtained from compound 1 in good yield. As described above, while the conventional method can obtain Compound 5 from Compound 1 in three steps, the production method of the present invention can obtain Compound 5 from Compound 1 in two steps. Therefore, this production method is a superior method for producing penem derivatives compared to conventional methods. In addition, in the production method of the present invention, compound 5 is obtained from compound 7 even when heated at 80°C, whereas compound 5 is hardly obtained even when compound 4 is heated to 100°C, and compound 5 is obtained even when heated to about 120°C. Compound 5 is then obtained.
In general, it is thought that lower temperatures produce fewer by-products in chemical reactions, and from this point of view as well, the production method of the present invention is superior to conventional methods. In addition, the reaction time of this method is shorter than that of conventional methods. In other words, in this method, the reaction time required to obtain 5 from 1 is approximately 5 hours, whereas in the conventional method, the reaction time required to obtain 4 from 3 is approximately 40 hours; The reaction time is approximately 15 hours. Therefore, the present method is superior to the conventional method as a method for commercially producing penem derivatives. Example 1 2-methylpenem-3-carboxylic acid methyl ester A 1 ml solution of 40 mg (0.17 mmol) of N-methoxalyl-4-acetylthioazetidin-2-one and 65 mg (0.52 mmol) of trimethyl phosphite in dioxane was heated at 95°C in a nitrogen stream for 15 hours, and then
Heat to reflux for 2.5 hours. The residue after the solvent was distilled off was separated and purified by preparative thin layer chromatography [developing solvent: benzene-ethyl acetate (5:1)] to give 8 mg.
(yield 23%) of the target product is obtained as crystals. When recrystallized from a hexane-ethyl acetate mixed solvent, the melting point
Gives needle-shaped crystals at 79.5-80℃. Elemental analysis value as C 8 H 9 NO 3 S Calculated value: C, 48.22; H, 4.55; N, 7.03; S, 16.09 Actual value: C, 48.40; H, 4.59; N, 6.99; S, 16.08 IR spectrum ν Nujol nax cm -1 : 1768, 1707, 1581 NMR spectrum (CDCl 3 ) δppm: 2.30 (3H, s), 3.36 (1H, dd, J = 172Hz),
3.75 (1H, dd, J = 12, 4Hz), 3.77 (3H, s),
5.68 (1H, dd, J=4,2Hz) Example 2 2-Methylpenem-3-carboxylic acid p-nitropenzyl ester N-p-nitrobenzyloxyoxalyl-4
-Acetylthioazetidin-2-one 84mg
(0.24mmol) and trimethyl phosphite 238mg
(1.92 mmol) in 11 ml of ethyl acetate solution under nitrogen stream.
After stirring at 65°C for 24 hours, the solvent and volatile substances were distilled off at 60°C under reduced pressure to give crude 4-acetylthio-1-
112 mg of [1-(p-nitrobenzyloxycarbonyl)trimethoxyphosphoranylidenemethyl]azetidin-2-one are obtained. A catalytic amount of p-hydroquinone is added to 112 mg of the phosphorane thus obtained, dissolved in 10 ml of xylene, and heated to 105 DEG C. for 21 hours under a nitrogen stream. After distilling off the solvent, the residue was separated and purified by preparative thin layer chromatography [developing solvent: ethyl acetate-benzene (1:8)] to obtain 37 mg (48%) of the desired product. When recrystallized from methylene chloride-ether, the melting point is 132-135℃.
Needle crystals are obtained. This product was manufactured by Woodward et al, J.Am.Chem.Soc. 101 6296
(1979)] (melting point 130~
132℃), IR spectrum, and NMR spectrum match. Example 3 (5R,6S)-2-(2-p-nitrobenzyloxycarbonylaminoethyl)-6-[(R)-1
-tert-butyldimethylsilyloxyethyl]
Penem-3-carboxylic acid p-nitrobenzyl ester (3S,4R)-N-p-nitrobenzyloxyoxalyl-4-(3-p-nitrobenzyloxycarbonylaminopropionylthio)-3-[(R)
A 17 ml solution of ethyl acetate containing 130 mg (0.18 mmol) of -1-tert-butyldimethylsilyloxyethyl]azetidin-2-one and 180 mg (1.45 mmol) of trimethyl phosphite was stirred at 65°C under a nitrogen stream for 26 hours.
The solvent and volatile substances were distilled off under reduced pressure at 60°C to give the crude (3S,4R)-4-(3-p-nitrobenzyloxycarbonylaminopropionylthio)-3-
155 mg of [(R)-1-tert-butyldimethylsilyloxyethyl]-1-[1-(p-nitrobenzyloxycarbonyl)trimethoxyphosphoranylidenemethyl]azetidin-2-one is obtained. Add a catalytic amount of p-hydroquinone to this, and xylene 15
ml for 24 hours at 105° C. under nitrogen flow. After distilling off into a solvent, the residue was separated and purified using preparative thin layer chromatography [developing solvent: benzene-ethyl acetate (1:1) mixed solvent] to obtain 43 mg (yield 35%) of the target product as an oil. Obtain it as a substance. IR spectrum ν liq nax cm -1 : 3400, 1797, 1700-1740 NMR spectrum (CDCl 3 ) δppm: 0.05 (3H, s), 0.08 (3H, s), 0.80 (9H, s),
1.16 (3H, d, J=6.5Hz), 2.8~3.5 (4H, m),
3.70 (1H, dd, J=4, 1.5Hz), 4.20 (1H,
m), 5.18 (2H, s), 5.14 (1H, d, J=15
Hz), 5.38 (1H, d, J = 15Hz), 5.60 (1H, d,
J=1.5Hz), 7.3-8.4 (8H) Example 4 2-Butylthiopenem-3-carboxylic acid p-nitrobenzyl ester N-methoxalyl-4-[(butylthio)thiocarbonyl]thioazetidin-2-one 171mg
(0.53mmol) and trimethyl phosphite 132mg
(1.06 mmol) in 3.5 ml of acetonitrile is stirred at 55°C in a nitrogen stream for 16.5 hours. The residue after the solvent was distilled off was separated and purified by preparative thin layer chromatography [developing solvent: benzene-ethyl acetate (10:1)] to obtain 39 mg (yield 27%) of the desired product as crystals. When recrystallized from ethanol, the melting point is 100 ~
Gives plate crystals at 101.5℃. Elemental analysis value C 11 H 15 NO 3 S 2 Calculated value: C, 48.32; H, 5.53; N, 5.12 Analysis value: C, 48.14; H, 5.52; N, 5.03 IR spectrum ν Nujol nax cm -1 ; 1769 , 1702 NMR spectrum ( CDCl3 ) δppm: 0.96 (3H, t-like), ~1.6 (4H, m), 2.99 (2H,
t, J = 7Hz), 3.49 (1H, dd, J = 17, 2
Hz), 3.84 (3H, s), 3.86 (1H, dd, J=17,
4Hz), 5.74 (1H, dd, J=4,2Hz) Example 5 2-Butylthiopenem-3-carboxylic acid p-nitrobenzyl ester N-p-nitrobenzyloxyoxalyl-4
- A solution of 116 mg (0.26 mmol) of [(butylthio)thiocarbonyl]thioazetidin-2-one and 260 mg (2.10 mmol) of trimethyl phosphite in 14 ml of ethyl acetate is stirred at 70°C under a nitrogen stream for 22 hours. After distilling off the solvent, 131 mg of the residue was subjected to column chromatography using 6 g of silica gel, and the objective was to obtain a substance with a melting point of 128 to 129°C from the portion eluted with benzene-ethyl acetate (20:1 to 10:1). 36 mg (yield 35
%) as crystals. This product is Japanese Patent Application No. 53-81658 (Japanese Patent Application No. 55-9034)
A compound obtained by the intramolecular Witzteich reaction of 4-[(butylthio)thiocarbonyl]thio-1-[1-(p-nitrobenzyloxycarbonyl)triphenylphosphoranylidenemethyl]azetidin-2-one described in The melting point, infrared absorption spectrum, and nuclear magnetic resonance spectrum match. IR spectrum ν nujol nax cm -1 ; 1786, 1677 nmr spectrum (CDCl 3 ) δppm; 0.93 (3H, t, J = 6Hz), 2.98 (2H, t, J =
7Hz), 3.50 (1H, dd, J=17, 2Hz), 3.91
(1H, dd, J = 17, 3.5Hz), 5.26 (1H, d, J
= 14Hz), 5.55 (1H, d, J = 14Hz), 5.77 (1H,
dd, J=3.5, 2Hz), 7.70 (2H, d), 8.32
(2H, d) Example 6 (5R, 6S)-2-[[2-(p-nitrobenzyloxycarbonylamino)ethyl]thio]-6
-[(R)-1-tert-butyldimethylsilyloxyethyl]penem-3-carboxylic acid p-nitrobenzyl ester (3S,4R)-N-p-nitrobenzyloxyoxalyl-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[[[2-(p-nitrobenzyloxycarbonylamino)ethyl] [thio]thiocarbonyl]thioazetidin-2-one
71mg (0.093mmol) and trimethyl phosphite 92mg
(0.74 mmol) in 9 ml of toluene in a nitrogen stream,
Heat and stir at 65-75°C for 34 hours. The residue after distilling off the solvent is separated and purified using preparative thin layer chromatography (developing solvent: chloroform-ethyl acetate (5:1)) to obtain 31 mg (47%) of the target product as an oily substance.This product The IR and NMR spectra match those of the compound described in Japanese Patent Application No. 54-44050. IR spectrum ν nujol nax cm -1 : 1780, 1710, 1670 nmr spectrum (CDCl 3 ) δppm: 0.03 (3H, s ), 0.07 (3H, s), 0.80 (9H, s),
1.20 (3H, d, J=6Hz), 3.04 (2H, m),
3.38 (2H, t, J = 5Hz), 3.66 (1H, dd, J =
4,2Hz), 4.12 (1H, m), 5.04 (1H, d, J
= 14Hz), 5.10 (2H, s), 5.37 (1H, d, J =
14Hz), 5.57 (1H, d, J=2Hz), 7.38 (2H,
d, J=9Hz), 7.50 (2H, d, J=9Hz),
8.58 (4H, d, J = 9Hz) Example 7 2-Methylthiopenem-3-carboxylic acid p-nitrobenzyl ester and 2-methoxypenem-3-carboxylic acid p-nitrobenzyl ester
【式】【formula】
【式】
N−p−ニトロベンジルオキシオキサリル−4
−〔(メトキシ)チオカルボニル〕チオアゼチジン
−2−オン256mg(0.67mmol)と亜リン酸トリメ
チル495mg(3.99mmol)の酢酸エチル33ml溶液を
窒素気流下65℃で22時間撹拌する。溶剤及び揮発
性物質を減圧下留去し粗製4−〔(メトキシ)チオ
カルボニル〕チオ−1−〔1−(p−ニトロベンジ
ルオキシカルボニル)トリメトキシホスホラニリ
デンメチル〕アゼチジン−2−オン307mgを得る。
IRスペクトル νCHCl3 naxcm-1:
1760,1637,1603,1513,1341
この粗製ホスホラン307mgとp−ハイドロキノ
ン触媒量のキシレン32ml溶液を窒素気流下130℃
で18時間加熱し、溶剤を留去する。残留物を分取
用薄層クロマトグラフイ(展開溶剤:ベンゼン−
酢酸エチル(2:1)〕で分離精製し、2−メチ
ルチオペネム誘導体42mg(収率18%、N−p−ニ
トロベンジルオキシオキサリル誘導体にもとづ
く)及び2−メトキシペネム誘導体8mg(収率
3.6%、N−p−ニトロベンジルオキシオキサリ
ル誘導体にもとづく)をそれぞれ結晶として得
る。
ここに得られた2−メチルチオ誘導体をアセト
ンから再結晶すると、融点165〜166℃の針状晶が
得られる。
元素分析値 C14H12N2O5S2として
計算値:C,47.71;H,3.43;N,7.95;
S,18.20
実測値:C,47.77;H,3.45;N,7.83;
S,18.14
IRスペクトル νKBr naxcm-1:
1800,1683
NMRスペクトル(CDCl3)δppm:
2.54(3H,s)、3.51(1H,dd,J=16,2Hz)、
3.84(1H,dd,J=16,3.5Hz)、5.24(1H,d,
J=14Hz)、5.47(1H,d,J=14Hz)、5.73
(1H,dd,J=3.5,2Hz)、7.62(2H,d,J
=8.5Hz)、8.22(2H,d,J=8.5Hz)
また、2−メトキシペネム誘導体をクロロホル
ム−ベンゼン混合溶剤で再結晶すると、融点196
〜198℃のプリズム晶が得られる。
元素分析値 C14H12N2O6Sとして
計算値:C,50.00;H,3.60;N,8.33
実測値:C,49.98;H,3.60;N,8.16
IRスペクトル νKBr naxcm-1:
1788,1689,1603,1563,1508,1339
NMRスペクトル(CDCl3)δppm:
3.43(1H,dd,J=17,2Hz)、3.86(1H,dd,
J=17,3.5Hz)、4.03(3H,s)、5.16(1H,
d,J=14Hz)、5.42(1H,d,J=14Hz)、
5.66(1H,dd,J=3.5,2Hz)、7.56(2H,d,
J=9Hz)、8.20(2H,d,J=9Hz)
実施例 8
(5R,6S)−2−[[(R)−1−メチル−2−
(p−ニトロベンジルオキシカルボニルアミノ)
エチル]チオ]−6−[(R)−1−tert−ブチル
ジメチルシリルオキシエチル]ペネム−3−カ
ルボン酸p−ニトロベンジルエステル
(3S,4R)−3−[(R)−1−tert−ブチルジ
メチルシリルオキシエチル]−4−[[[(R)−1−
メチル−2−(p−ニトロベンジルオキシカルボ
ニルアミノ)エチル]チオ]チオカルボニル]チ
オ−1−(p−ニトロベンジルオキサリル)アゼ
チジン−2−オン374mg(0.48mmol)及び亜リン
酸トリメチル475mg(3.83mmol)のジオキサン40
ml溶液を、窒素気流下75℃で91時間撹拌する。溶
剤を留去し、残留物を分取用薄層クロマトグラフ
イー〔展開溶剤、ベンゼン:酢酸エチル=1:
2〕で精製した後、さらに分取用薄層クロマトグ
ラフイー〔展開溶剤、クロロホルム:酢酸エチル
=8:1〕で再精製し、目的物92mg(収率26%)
を得た。ベンゼンより再結晶をおこない、融点
163−164℃を有する純品を得た。
IRスペクトル νKBr naxcm-1:3400(br.),1785,
1735,1690
比旋光度〔α〕25 D+29.6゜(C=0.47,CHCl3)
NMRスペクトル(CDCl3)δppm:
0.03,0.06(6H,s)、0.83(9H,s)、1.23
(3H,d,J=6Hz)、〜1.3(3H,m)、3.45
(3H,m)、3.71(1H,dd,J=4,1.5Hz)、
4.2(2H,m)、5.17(2H,s)、5.18(1H,d,
J=14.5Hz)、5.38(1H,d,J=14.5Hz)、〜
5.4(1H,m)、5.61(1H,d,J=1.5Hz)、7.48
(2H,d)、7.60(2H,d)、8.16(4H,d)
参考例 1
N−メトキサリル−4−アセチルチオアゼチジ
ン−2−オン
4−アセチルチオアゼチジン−2−オン977mg
(6.74mmol)とトリエチルアミン1.02g
(10.1mmol)の塩化メチレン20ml溶液に、氷冷
下、撹拌しながらメトキサリルクロリド1.24g
(10.1mmol)を加え、同温度に20分間保つ。反応
液を塩化メチレンで希釈し、リン酸緩衝液(PH
7)で洗浄し乾燥する。溶剤を留去した後の残留
物をシリカゲル20gを用いるカラムクロマトグラ
フイーに付し、ベンゼン−酢酸エチル(10:1〜
9:1)混合溶剤によつて溶出される部分を集
め、1.40g(収率90%)の目的物を結晶として得
る。アセトン−ジイソプロピルエーテル混合溶剤
で再結晶すると、融点69〜70.5℃のプリズム晶が
得られる。
元素分析値 C8H9NO5Sとして
計算値:C,41.56;H,3.92;N,6.06;
S,13.87
実測値:C,41.49;H,3.88;N,6.06;
S,13.93
IRスペクトル νNujol naxcm-1:
1812,1746,1720,1701
NMRスペクトル(CDCl3)δppm:
2.39(3H,s)、3.23(1H,dd,J=18,4Hz)、
3.81(1H,dd,J=18,6.5Hz)、3.92(3H,
s)、5.81(1H,dd,J=6.5,4Hz)
参考例 2
N−p−ニトロベンジルオキシオキサリル−4
−アセチルチオアゼチジン−2−オン
氷冷下4−アセチルチオアゼチジン−2−オン
1.19g(8.2mmol)の塩化メチレン16ml溶液に、
トリエチルアミン1.08g(10.7mmol)、p−ニト
ロベンジルオキシオキサリルクロリド2.60g
(10.7mmol)を順次加え、35分間同温度で撹拌す
る。ついで、塩化メチレンで希釈した後、リン酸
緩衝液(PH7.0)で2回洗浄し乾燥する。溶剤を
留去した後の残留物をシリカゲル25gを用いるカ
ラムクロマトグラフイーに付す。ベンゼン−酢酸
エチル(10:1)混合溶剤によつて溶出される部
分を集めベンゼン−ジイソプロピルエーテルより
再結晶すると、2.50g(85%)の目的物が針状
晶、融点117〜118℃として得られる。
元素分析値 C14H12N2O7Sとして
計算値:C,47.73;H,3.43;N,7.95;
S,9.10
実測値:C,47.94;H,3.46;N,8.01;
S,8.99
IRスペクトル νNujol axcm-1
1803,1747,1718,1702,1602,1522,1350
NMRスペクトル(CDCl3)δppm:
2.31(3H,s)、3.21(1H,dd,J=18,4Hz)、
3.76(1H,dd,J=18,6Hz)、5.39(2H,s)、
5.71(1H,dd,J=6,4Hz)、7.59(2H,d,
J=9Hz)、8.23(2H,d,J=9Hz)
参考例 3
(3S,4R)−N−p−ニトロベンジルオキシオ
キサリル−4−(3−p−ニトロベンジルオキ
シカルボニルアミノプロピオニルチオ)−3−
〔(R)−1−tert−ブチルジメチルシリルオキ
シエチル〕アゼチジン−2−オン
(3S,4R)−4−(3−p−ニトロベンジルオ
キシカルボニルアミノプロピオニルチオ)−3−
〔(R)−1−tert−ブチルジメチルシリルオキシ
エチル〕アゼチジン−2−オン150mg
(0.29mmol)とトリエチルアミン89mg
(0.88mmol)の塩化メチレン3ml溶液を−10℃に
冷却し、撹拌しながらp−ニトロベンジルオキシ
オキサリルクロリド214mg(0.88mmol)を加え、
同温度に30分間保持する。ついで、氷冷したリン
酸緩衝液と塩化メチレンを加え、有機層を水洗す
る。乾燥後、溶剤を留去し残留物をシリカゲルカ
ラムクロマトグラフイーに付す。ベンゼン−酢酸
エチル(3:1)混合溶剤で溶出される部分を集
め、目的物148mg(収率70%)を結晶として得る。
IRスペクトル νNujol naxcm-1:
1805,1745,1730,1715,1700
NMRスペクトル(CDCl3)δppm:
0.05(3H,s)、0.10(3H,s)、0.91(9H,s)、
1.21(3H,d,J=7Hz)、2.7〜3.8(5H,m)、
4.12(1H,m)、5.20(2H,s)、5.39(2H,s)、
5.78(3H,d,J=4Hz)、7.45(2H,d,J=
9Hz)、7.51(2H,d,J=9Hz)、8.14(2H,
d,J=9Hz)、8.18(2H,d,J=9Hz)
参考例 4
N−メトキサリル−4−〔(ブチルチオ)チオカ
ルボニル〕チオアゼチジン−2−オン
4−〔(ブチルチオ)チオカルボニル〕チオアゼ
チジン−2−オン235mg(1.0mmol)とトリエチ
ルアミン151mg(1.5mmol)の塩化メチレン4ml
溶液にメトキシサリルクロリド183mg(1.5mmol)
を、氷冷下、撹拌しながら加え、そのまま30分間
撹拌を続ける。塩化メチレンで反応液を希釈した
後、リン酸緩衝液(PH7)で洗浄し乾燥する。溶
剤留去後の残留物をシリカゲル6gを用いるカラ
ムクロマトグラフイーに付し、ベンゼンで溶出さ
れる部分を集め、262mg(収率82%)の目的物を
油状物質として得る。
IRスペクトル νCHCl3 naxcm-1:
1820,1755,1710
NMRスペクトル(CDCl3)δppm:
0.88(3H,t−様,J=6Hz)、〜1.5(4H,
m)、3.25(1H,dd,J=17,3.5Hz)、3.33
(2H,t,J=7Hz)、3.89(3H,s)、3.89
(1H,dd,J=17,6Hz)、6.15(1H,dd,J
=6,3.5Hz)
参考例 5
N−p−ニトロベンジルオキシオキサリル−4
−〔(ブチルチオ)チオカルボニル〕チオアゼチ
ジン−2−オン
4−〔(ブチルチオ)チオカルボニル〕チオアセ
チジン−2−オン226g(0.96mmol)とトリエチ
ルアミン132mg(1.31mmol)の塩化メチレン7ml
溶液を−15℃に冷却し、撹拌しながらp−ニトロ
ベンジルオキシオキサリルクロリド316mg
(1.30mmol)を加える。30分間同温度で撹拌した
後、塩化メチレンで希釈しリン酸緩衝液(PH7)
で洗う。乾燥後、溶剤を留去し残留物をシリカゲ
ル11gを用いるカラムクロマトグラフイーに付
し、ベンゼン−酢酸エチル(20:1〜15:1)混
合溶剤で溶出される部分を集め、390mg(収率88
%)の目的物を油状物質として得る。
IRスペクトル νCHCl3 naxcm-1:
1820,1761,1713,1603,1517,1342
NMRスペクトル(CDCl3)δppm:
0.91(3H,t−様)、〜1.6(4H,m)、3.29(1H,
dd,J=17.5,4Hz)、3.34(2H,t,J=7
Hz)、3.93(1H,dd,J=17.5,6Hz)、5.45
(2H,s)、6.19(1H,dd,J=6,4Hz)、
7.67(2H,d,J=8.5Hz)、8.31(2H,d,J
=8.5Hz)
参考例 6
(3S,4R)−N−p−ニトロベンジルオキシオ
キサリル−3−〔(R)−1−tert−ブチルジメ
チルシリルオキシエチル〕−4−〔〔〔2−(p−
ニトロベンジルオキシカルボニルアミノ)エチ
ル〕チオ〕チオカルボニル〕チオアゼチジン−
2−オン
(3S,4R)−3−〔(R)−1−tert−ブチルジ
メチルシリルオキシエチル〕−4−〔〔〔2−(p−
ニトロベンジルオキシカルボニルアミノ)エチ
ル〕チオ〕チオカルボニルチオ〕チオアゼチジン
−2−オン100mg(0.18mmol)とトリエチルアミ
ン54mg(0.53mmol)の塩化メチレン3ml溶液を
−10℃に冷却し、p−ニトロベンジルオキシオキ
サリルクロリド130mg(0.53mmol)を加え、同温
度に20分間保つ。氷冷したリン酸緩衝液(PH7)、
塩化メチレンを順次加え、有機層を水洗し乾燥す
る。溶剤留去後の残留物209mgをシリカゲル5g
を用いるカラムクロマトグラフイーに付しベンゼ
ン−酢酸エチル(15:1)混合溶剤で溶出される
部分を集め、106mg(収率77%)の目的物を油状
物質として得る。
IRスペクトル νCHCl3 naxcm-1
3460,1823,1769,1730,1607,1517,1353
NMRスペクトル(CDCl3)δppm:
0.00(3H,s)、0.10(3H,s)、0.83(9H,s)、
1.23(3H,d,J=6Hz)、〜3.6(4H,m)、
4.40(1H,td,J=6,4Hz)5.16(2H,s)、
5.40(2H,s)、〜5.4(1H,m)、6.72(1H,d,
J=4Hz)、7.50(2H,d,J=9Hz)、7.56
(2H,d,J=9Hz)、8.19(2H,d,J=9
Hz)、8.23(2H,d,J=9Hz)
参考例 7
N−p−ニトロベンジルオキシオキサリル−4
−〔(メトキシ)チオカルボニル〕チオアゼチジ
ン−2−オン
4−〔(メトキシ)チオカルボニル〕チオアゼチ
ジン−2−オン250mg(1.41mmol)とトリエチル
アミン185mg(1.83mmol)の塩化メチレン6ml溶
液を−10℃に冷却し、撹拌下p−ニトロベンジル
オキシオキサリルクロリド447mg(1.83mmol)を
加え、20分間さらに撹拌する。反応液に氷冷した
リン酸緩衝液(PH7)、塩化メチレンを順次加え、
有機層を水洗する。乾燥後、溶剤を留去し残留物
をシリカゲル11gを用いるカラムクロマトグラフ
イーに付し、ベンゼン−酢酸エチル(30:1〜
20:1)混合溶剤で溶出される部分を集め、目的
物536mg(収率99%)を油状物質として得る。
IRスペクトル νCHCl3 naxcm-1:
1821,1762,1717,1605,1520
NMRスペクトル(CDCl3)δppm:
3.26(1H,dd,J=17,4Hz)、3.86(1H,dd,
J=17,6Hz)、4.16(3H,s)、5.36(2H,
s)、5.81(1H,dd,J=6,4Hz)、7.53(2H,
d,J=8Hz)、8.16(2H,d,=8Hz)
参考例 8
(3S,4R)−3−[(R)−1−tert−ブチルジ
メチルシリルオキシエチル]−4−[[[(R)−1
−メチル−2−(p−ニトロベンジルオキシカ
ルボニルアミノ)エチル]チオ]チオカルボニ
ル]チオ−1−(p−ニトロベンジルオキサリ
ル)アセチジン−2−オン
(3S,4R)−3−[(R)−tert−ブチルジメチ
ルシリルオキシエチル]−4−[[[(R)−1−メチ
ル−2−(p−ニトロベンジルオキシカルボニル
アミノ)エチル]チオ]チオカルボニル]チオア
ゼチジン−2−オン326mg(0.57mmol)とトリエ
チルアミン172mg(1.70mmol)の塩化メチレン10
ml溶液を塩−氷浴で−10℃に冷却し、窒素気流
下、撹拌しながらp−ニトロベンジルオキサリル
クロリド416mg(1.71mmol)を加える。同温度で
25分間撹拌した後リン酸緩衝液(PH7)10mlを加
え、クロロホルムで抽出し水洗する。抽出液を乾
燥後、溶剤を留去し、残留物をシリカゲル5gを
用いるカラムクロマトグラフイーに付し、ベンゼ
ン−酢酸エチル(15:1)混合溶剤で溶出される
部分を集め、目的物385mg(収率87%)を油状物
質として得た。
IRスペクトル νCHCl3 naxcm-1:1815,1760,1720,
1607,1511
NMRスペクトル(CDCl3)δppm:0.10(6H,
s)、0.83(9H,s)、1.21(3H,d,J=6
Hz)、1.43(3H,d,J=7Hz)、3.2〜3.7(3H,
m)、4.0〜4.6(2H,m)、5.13(2H,s)、5.34
(2H,s)、6.70(1H,d,J=4Hz)、7.43
(2H,d)、7.50(2H,d)、8.13(2H,d)、
8.17(2H,d)[Formula] N-p-nitrobenzyloxyoxalyl-4
- A solution of 256 mg (0.67 mmol) of [(methoxy)thiocarbonyl]thioazetidin-2-one and 495 mg (3.99 mmol) of trimethyl phosphite in 33 ml of ethyl acetate is stirred at 65°C under a nitrogen stream for 22 hours. The solvent and volatile substances were distilled off under reduced pressure to obtain 307 mg of crude 4-[(methoxy)thiocarbonyl]thio-1-[1-(p-nitrobenzyloxycarbonyl)trimethoxyphosphoranylidenemethyl]azetidin-2-one. obtain. IR spectrum ν CHCl3 nax cm -1 : 1760, 1637, 1603, 1513, 1341 A solution of 307 mg of this crude phosphorane and 32 ml of xylene containing a catalytic amount of p-hydroquinone was heated at 130°C under a nitrogen stream.
Heat for 18 hours and evaporate the solvent. The residue was analyzed by preparative thin layer chromatography (developing solvent: benzene).
42 mg of 2-methylthiopenem derivative (yield 18%, based on N-p-nitrobenzyloxyoxalyl derivative) and 8 mg of 2-methoxypenem derivative (yield
3.6%, based on the N-p-nitrobenzyloxyoxalyl derivative), respectively, are obtained as crystals. When the 2-methylthio derivative obtained here is recrystallized from acetone, needle-shaped crystals with a melting point of 165-166°C are obtained. Elemental analysis value C 14 H 12 N 2 O 5 S 2 Calculated value: C, 47.71; H, 3.43; N, 7.95; S, 18.20 Actual value: C, 47.77; H, 3.45; N, 7.83; S, 18.14 IR spectrum ν KBr nax cm -1 : 1800, 1683 NMR spectrum (CDCl 3 ) δppm: 2.54 (3H, s), 3.51 (1H, dd, J=16, 2Hz),
3.84 (1H, dd, J=16, 3.5Hz), 5.24 (1H, d,
J=14Hz), 5.47 (1H, d, J=14Hz), 5.73
(1H, dd, J = 3.5, 2Hz), 7.62 (2H, d, J
= 8.5Hz), 8.22 (2H, d, J = 8.5Hz) In addition, when the 2-methoxypenem derivative is recrystallized with a chloroform-benzene mixed solvent, the melting point is 196
Prism crystals at ~198°C are obtained. Elemental analysis value as C 14 H 12 N 2 O 6 S Calculated value: C, 50.00; H, 3.60; N, 8.33 Actual value: C, 49.98; H, 3.60; N, 8.16 IR spectrum ν KBr nax cm -1 : 1788, 1689, 1603, 1563, 1508, 1339 NMR spectrum (CDCl 3 ) δppm: 3.43 (1H, dd, J = 17, 2Hz), 3.86 (1H, dd,
J=17, 3.5Hz), 4.03 (3H, s), 5.16 (1H,
d, J=14Hz), 5.42 (1H, d, J=14Hz),
5.66 (1H, dd, J=3.5, 2Hz), 7.56 (2H, d,
J=9Hz), 8.20 (2H, d, J=9Hz) Example 8 (5R,6S)-2-[[(R)-1-methyl-2-
(p-nitrobenzyloxycarbonylamino)
ethyl]thio]-6-[(R)-1-tert-butyldimethylsilyloxyethyl]penem-3-carboxylic acid p-nitrobenzyl ester (3S,4R)-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[[[(R)-1-
Methyl-2-(p-nitrobenzyloxycarbonylamino)ethyl]thio]thiocarbonyl]thio-1-(p-nitrobenzyloxalyl)azetidin-2-one 374 mg (0.48 mmol) and trimethyl phosphite 475 mg (3.83 mmol) ) dioxane 40
ml solution is stirred at 75° C. for 91 hours under nitrogen flow. The solvent was distilled off, and the residue was subjected to preparative thin layer chromatography [developing solvent, benzene: ethyl acetate = 1:
2], and then repurified by preparative thin layer chromatography [developing solvent, chloroform:ethyl acetate = 8:1] to obtain 92 mg of the target product (yield 26%).
I got it. Recrystallize from benzene, melting point
A pure product with a temperature of 163-164°C was obtained. IR spectrum ν KBr nax cm -1 : 3400 (br.), 1785,
1735, 1690 Specific rotation [α] 25 D +29.6° (C = 0.47, CHCl 3 ) NMR spectrum (CDCl 3 ) δppm: 0.03, 0.06 (6H, s), 0.83 (9H, s), 1.23
(3H, d, J=6Hz), ~1.3 (3H, m), 3.45
(3H, m), 3.71 (1H, dd, J=4, 1.5Hz),
4.2 (2H, m), 5.17 (2H, s), 5.18 (1H, d,
J = 14.5Hz), 5.38 (1H, d, J = 14.5Hz), ~
5.4 (1H, m), 5.61 (1H, d, J = 1.5Hz), 7.48
(2H, d), 7.60 (2H, d), 8.16 (4H, d) Reference example 1 N-methoxalyl-4-acetylthioazetidin-2-one 4-Acetylthioazetidin-2-one 977mg
(6.74mmol) and triethylamine 1.02g
(10.1 mmol) of methoxalyl chloride in 20 ml of methylene chloride solution while stirring under ice cooling.
(10.1 mmol) and keep at the same temperature for 20 minutes. The reaction solution was diluted with methylene chloride and added to phosphate buffer (PH
7) Wash and dry. After distilling off the solvent, the residue was subjected to column chromatography using 20 g of silica gel, and benzene-ethyl acetate (10:1 to
Collect the portion eluted with the 9:1) mixed solvent to obtain 1.40 g (90% yield) of the target product as crystals. Recrystallization with acetone-diisopropyl ether mixed solvent yields prismatic crystals with a melting point of 69-70.5°C. Elemental analysis value as C 8 H 9 NO 5 S Calculated value: C, 41.56; H, 3.92; N, 6.06; S, 13.87 Actual value: C, 41.49; H, 3.88; N, 6.06; S, 13.93 IR spectrum ν Nujol nax cm -1 : 1812, 1746, 1720, 1701 NMR spectrum (CDCl 3 ) δppm: 2.39 (3H, s), 3.23 (1H, dd, J = 18, 4Hz),
3.81 (1H, dd, J=18, 6.5Hz), 3.92 (3H,
s), 5.81 (1H, dd, J = 6.5, 4Hz) Reference example 2 N-p-nitrobenzyloxyoxalyl-4
-acetylthioazetidin-2-one 4-acetylthioazetidin-2-one under ice cooling
In a solution of 1.19 g (8.2 mmol) in methylene chloride in 16 ml,
Triethylamine 1.08g (10.7mmol), p-nitrobenzyloxyoxalyl chloride 2.60g
(10.7 mmol) were added one after another and stirred at the same temperature for 35 minutes. Then, after diluting with methylene chloride, it is washed twice with phosphate buffer (PH7.0) and dried. After distilling off the solvent, the residue was subjected to column chromatography using 25 g of silica gel. The fraction eluted with a mixed solvent of benzene-ethyl acetate (10:1) was collected and recrystallized from benzene-diisopropyl ether to yield 2.50 g (85%) of the desired product as needle-shaped crystals, melting point 117-118°C. It will be done. Elemental analysis value as C 14 H 12 N 2 O 7 S Calculated value: C, 47.73; H, 3.43; N, 7.95; S, 9.10 Actual value: C, 47.94; H, 3.46; N, 8.01; S, 8.99 IR Spectrum ν Nujol ax cm -1 1803, 1747, 1718, 1702, 1602, 1522, 1350 NMR spectrum (CDCl 3 ) δppm: 2.31 (3H, s), 3.21 (1H, dd, J = 18, 4Hz),
3.76 (1H, dd, J = 18, 6Hz), 5.39 (2H, s),
5.71 (1H, dd, J=6,4Hz), 7.59 (2H, d,
J=9Hz), 8.23 (2H, d, J=9Hz) Reference example 3 (3S,4R)-N-p-nitrobenzyloxyoxalyl-4-(3-p-nitrobenzyloxycarbonylaminopropionylthio)-3 −
[(R)-1-tert-butyldimethylsilyloxyethyl]azetidin-2-one (3S,4R)-4-(3-p-nitrobenzyloxycarbonylaminopropionylthio)-3-
[(R)-1-tert-butyldimethylsilyloxyethyl]azetidin-2-one 150mg
(0.29mmol) and triethylamine 89mg
(0.88 mmol) in methylene chloride was cooled to -10°C, and while stirring, 214 mg (0.88 mmol) of p-nitrobenzyloxyoxalyl chloride was added.
Hold at the same temperature for 30 minutes. Then, ice-cold phosphate buffer and methylene chloride are added, and the organic layer is washed with water. After drying, the solvent is distilled off and the residue is subjected to silica gel column chromatography. The portion eluted with a benzene-ethyl acetate (3:1) mixed solvent was collected to obtain 148 mg (yield 70%) of the desired product as crystals. IR spectrum ν Nujol nax cm -1 : 1805, 1745, 1730, 1715, 1700 NMR spectrum (CDCl 3 ) δppm: 0.05 (3H, s), 0.10 (3H, s), 0.91 (9H, s),
1.21 (3H, d, J=7Hz), 2.7-3.8 (5H, m),
4.12 (1H, m), 5.20 (2H, s), 5.39 (2H, s),
5.78 (3H, d, J = 4Hz), 7.45 (2H, d, J =
9Hz), 7.51 (2H, d, J=9Hz), 8.14 (2H,
d, J = 9Hz), 8.18 (2H, d, J = 9Hz) Reference example 4 N-methoxalyl-4-[(butylthio)thiocarbonyl]thioazetidin-2-one 235 mg (1.0 mmol) of 4-[(butylthio)thiocarbonyl]thioazetidin-2-one and 151 mg (1.5 mmol) of triethylamine in 4 ml of methylene chloride.
183 mg (1.5 mmol) of methoxysalyl chloride in solution
Add while stirring under ice-cooling, and continue stirring for 30 minutes. After diluting the reaction solution with methylene chloride, it is washed with phosphate buffer (PH7) and dried. The residue after the solvent was distilled off was subjected to column chromatography using 6 g of silica gel, and the portion eluted with benzene was collected to obtain 262 mg (yield: 82%) of the desired product as an oily substance. IR spectrum ν CHCl3 nax cm -1 : 1820, 1755, 1710 NMR spectrum (CDCl 3 ) δppm: 0.88 (3H, t-like, J=6Hz), ~1.5 (4H,
m), 3.25 (1H, dd, J=17, 3.5Hz), 3.33
(2H, t, J=7Hz), 3.89 (3H, s), 3.89
(1H, dd, J = 17, 6Hz), 6.15 (1H, dd, J
=6,3.5Hz) Reference example 5 N-p-nitrobenzyloxyoxalyl-4
-[(butylthio)thiocarbonyl]thioazetidin-2-one 226 g (0.96 mmol) of 4-[(butylthio)thiocarbonyl]thioacetidin-2-one and 132 mg (1.31 mmol) of triethylamine in 7 ml of methylene chloride.
Cool the solution to -15°C and add 316 mg of p-nitrobenzyloxyoxalyl chloride while stirring.
(1.30mmol). After stirring at the same temperature for 30 minutes, dilute with methylene chloride and add phosphate buffer (PH7).
wash with After drying, the solvent was distilled off and the residue was subjected to column chromatography using 11 g of silica gel, and the portion eluted with a mixed solvent of benzene-ethyl acetate (20:1 to 15:1) was collected to give 390 mg (yield 88
%) of the desired product as an oily substance. IR spectrum ν CHCl3 nax cm -1 : 1820, 1761, 1713, 1603, 1517, 1342 NMR spectrum (CDCl 3 ) δppm: 0.91 (3H, t-like), ~1.6 (4H, m), 3.29 (1H,
dd, J = 17.5, 4Hz), 3.34 (2H, t, J = 7
Hz), 3.93 (1H, dd, J=17.5, 6Hz), 5.45
(2H, s), 6.19 (1H, dd, J=6.4Hz),
7.67 (2H, d, J = 8.5Hz), 8.31 (2H, d, J
=8.5Hz) Reference example 6 (3S,4R)-N-p-nitrobenzyloxyoxalyl-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[[[2-(p-
Nitrobenzyloxycarbonylamino)ethyl]thio]thiocarbonyl]thioazetidine-
2-on (3S,4R)-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[[[2-(p-
A solution of 100 mg (0.18 mmol) of nitrobenzyloxycarbonylamino)ethyl]thio]thiocarbonylthio]thioazetidin-2-one and 54 mg (0.53 mmol) of triethylamine in 3 ml of methylene chloride was cooled to -10°C, and p-nitrobenzyloxyoxalyl was added. Add 130 mg (0.53 mmol) of chloride and keep at the same temperature for 20 minutes. ice-cold phosphate buffer (PH7),
Methylene chloride is sequentially added, and the organic layer is washed with water and dried. 209 mg of the residue after solvent distillation was added to 5 g of silica gel.
The fraction eluted with a benzene-ethyl acetate (15:1) mixed solvent was collected and 106 mg (yield 77%) of the desired product was obtained as an oily substance. IR spectrum ν CHCl3 nax cm -1 3460, 1823, 1769, 1730, 1607, 1517, 1353 NMR spectrum (CDCl 3 ) δppm: 0.00 (3H, s), 0.10 (3H, s), 0.83 (9H, s),
1.23 (3H, d, J=6Hz), ~3.6 (4H, m),
4.40 (1H, td, J=6,4Hz) 5.16 (2H, s),
5.40 (2H, s), ~5.4 (1H, m), 6.72 (1H, d,
J=4Hz), 7.50 (2H, d, J=9Hz), 7.56
(2H, d, J=9Hz), 8.19 (2H, d, J=9
Hz), 8.23 (2H, d, J = 9Hz) Reference example 7 N-p-nitrobenzyloxyoxalyl-4
-[(methoxy)thiocarbonyl]thioazetidin-2-one A solution of 250 mg (1.41 mmol) of 4-[(methoxy)thiocarbonyl]thioazetidin-2-one and 185 mg (1.83 mmol) of triethylamine in 6 ml of methylene chloride was cooled to -10°C, and with stirring, 447 mg of p-nitrobenzyloxyoxalyl chloride ( 1.83 mmol) and further stirred for 20 minutes. Ice-cold phosphate buffer (PH7) and methylene chloride were sequentially added to the reaction solution.
Wash the organic layer with water. After drying, the solvent was distilled off and the residue was subjected to column chromatography using 11 g of silica gel.
20:1) Collect the portion eluted with a mixed solvent to obtain 536 mg (yield 99%) of the target product as an oily substance. IR spectrum ν CHCl3 nax cm -1 : 1821, 1762, 1717, 1605, 1520 NMR spectrum (CDCl 3 ) δppm: 3.26 (1H, dd, J=17, 4Hz), 3.86 (1H, dd,
J = 17, 6Hz), 4.16 (3H, s), 5.36 (2H,
s), 5.81 (1H, dd, J=6,4Hz), 7.53 (2H,
d, J = 8 Hz), 8.16 (2H, d, = 8 Hz) Reference example 8 (3S, 4R)-3-[(R)-1-tert-butyldimethylsilyloxyethyl]-4-[[[(R )-1
-Methyl-2-(p-nitrobenzyloxycarbonylamino)ethyl]thio]thiocarbonyl]thio-1-(p-nitrobenzyloxalyl)acetidin-2-one (3S,4R)-3-[(R)-tert-butyldimethylsilyloxyethyl]-4-[[[(R)-1-methyl-2-(p-nitrobenzyloxycarbonylamino)ethyl]thio] thiocarbonyl]thioazetidin-2-one 326 mg (0.57 mmol) and triethylamine 172 mg (1.70 mmol) in methylene chloride 10
ml solution was cooled to -10°C in a salt-ice bath, and 416 mg (1.71 mmol) of p-nitrobenzyloxalyl chloride was added with stirring under a nitrogen stream. at the same temperature
After stirring for 25 minutes, add 10 ml of phosphate buffer (PH7), extract with chloroform, and wash with water. After drying the extract, the solvent was distilled off, the residue was subjected to column chromatography using 5 g of silica gel, and the portion eluted with a mixed solvent of benzene-ethyl acetate (15:1) was collected, yielding 385 mg of the target product ( Yield: 87%) was obtained as an oil. IR spectrum ν CHCl3 nax cm -1 : 1815, 1760, 1720,
1607, 1511 NMR spectrum (CDCl 3 ) δppm: 0.10 (6H,
s), 0.83 (9H, s), 1.21 (3H, d, J=6
Hz), 1.43 (3H, d, J=7Hz), 3.2-3.7 (3H,
m), 4.0-4.6 (2H, m), 5.13 (2H, s), 5.34
(2H, s), 6.70 (1H, d, J=4Hz), 7.43
(2H, d), 7.50 (2H, d), 8.13 (2H, d),
8.17 (2H, d)
Claims (1)
R4A−基(式中R4は水酸基、アルコキシ基、ア
シルオキシ基、トリアルキルシリルオキシ基、ア
ルキルチオ基、またはアシルアミノ基を示し、A
はトリフルオロメチル基で置換されていてもよい
アルキリデン基を示す。)を表わし、R2はアルキ
ル基、アルケニル基、アラルキル基、アリール
基、またはR5B−基(式中、R5は水酸基、アル
コキシ基、アシルオキシ基、トリアルキルシリル
オキシ基、カルボキシル基、アルコキシカルボニ
ル基、アラルキルオキシカルボニル基、アルキル
チオ基、またはアシルアミノ基を示し、Bはアル
キレン基を示す。)を表わし、R3はカルボキシル
基の保護基を表わし、Xは酸素原子または硫黄原
子を表わし、Yは酸素原子、硫黄原子またはメチ
レン基若しくはアルキル置換メチレン基を表わ
し、またR2−Y−基はメチル基を表わしてもよ
い。〕 を有するアゼチジン−2−オン誘導体を亜リン酸
トリエステルあるいは亜リン酸トリアミドと加熱
することを特徴とする一般式 (式中、R1,R2,R3およびYは上述したもの
と同意義を示す。) を有するペネム−3−カルボン酸誘導体を製造す
る方法。 2 一般式 〔式中、R1は水素原子、アルキル基または
R4A−基(式中、R4は水酸基、アルコキシ基、
アシルオキシ基、トリアルキルシリルオキシ基、
アルキルチオ基またはアシルアミノ基を示し、A
はトリフルオロメチル基で置換されていてもよい
アルキリデン基を示す。)を表わし、R2はアルキ
ル基、アルケニル基、アラルキル基、アリール基
またはR5−B−基(式中、R5は水酸基、アルコ
キシ基、アシルオキシ基、トリアルキルシリルオ
キシ基、カルボキシル基、アルコキシカルボニル
基、アラルキルオキシカルボニル基、アルキルチ
オ基またはアシルアミノ基を示し、Bはアルキレ
ン基を示す。)を表わし、R3はカルボキシル基の
保護基を表わし、Xは酸素原子または硫黄原子を
表わし、Yは酸素原子、硫黄原子またはメチレン
基若しくはアルキル置換メチレン基を表わし、ま
たR2−Y−基はメチル基を表わしてもよい。〕 を有するアゼチジン−2−オン誘導体を一般式 (R4)3P (式中、R4はアルコキシ基またはジアルキル
アミノ基を表わす。) を有する亜リン酸トリアルキルあるいは亜リン酸
トリアミドと反応させて一般式 (式中、R1,R2,R3,R4,XおよびYは前述
したものと同意義を示す。) を有するリン−イリド化合物を製造し、これを単
離し次いでこれを加熱することを特徴とする一般
式 (式中、R1,R2,R3およびYは前述したもの
と同意義を示す。) を有するペネム−3−カルボン酸誘導体を製造す
る方法。 3 一般式 〔式中、R1は水素原子、アルキル基または
R4A−基(式中、R4は水酸基、アルコキシ基、
アシルオキシ基、トリアルキルシリルオキシ基、
アルキルチオ基またはアシルアミノ基を示し、A
はトリフルオロメチル基で置換されていてもよい
アルキリデン基を示す。)を表わし、R2はアルキ
ル基、アルケニル基、アラルキル基、アリール基
またはR5−B−基(式中、R5は水酸基、アルコ
キシ基、アシルオキシ基、トリアルキルシリルオ
キシ基、カルボキシル基、アルコキシカルボニル
基、アラルキルオキシカルボニル基、アルキルチ
オ基またはアシルアミノ基を示し、Bはアルキレ
ン基を示す。)を表わし、R3はカルボキシル基の
保護基を表わし、Xは酸素原子または硫黄原子を
表わし、Yは酸素原子、硫黄原子またはメチレン
基若しくはアルキル置換メチレン基を表わし、ま
たR2−Y−基はメチル基を表わしてもよく、R4
はアルコキシ基またはジアルキルアミノ基を表わ
す。〕 を有するリン−イリド化合物を加熱することを特
徴とする一般式 (式中、R1,R2,R3およびYは前述したもの
と同意義を示す。) を有するペネム−3−カルボン酸誘導体を製造す
る方法。[Claims] 1. General formula [In the formula, R 1 is a hydrogen atom, an alkyl group, or
R 4 A- group (wherein R 4 represents a hydroxyl group, an alkoxy group, an acyloxy group, a trialkylsilyloxy group, an alkylthio group, or an acylamino group,
represents an alkylidene group optionally substituted with a trifluoromethyl group. ), R 2 is an alkyl group, alkenyl group, aralkyl group, aryl group, or R 5 B- group (wherein R 5 is a hydroxyl group, an alkoxy group, an acyloxy group, a trialkylsilyloxy group, a carboxyl group, an alkoxy represents a carbonyl group, aralkyloxycarbonyl group, alkylthio group, or acylamino group, B represents an alkylene group), R 3 represents a carboxyl group protecting group, X represents an oxygen atom or a sulfur atom, and Y represents an oxygen atom, a sulfur atom, a methylene group or an alkyl-substituted methylene group, and the R 2 -Y- group may represent a methyl group. ] A general formula characterized in that an azetidin-2-one derivative having the following is heated with a phosphorous triester or a phosphorous triamide. (In the formula, R 1 , R 2 , R 3 and Y have the same meanings as described above.) A method for producing a penem-3-carboxylic acid derivative having the following formula: 2 General formula [In the formula, R 1 is a hydrogen atom, an alkyl group, or
R 4 A- group (wherein R 4 is a hydroxyl group, an alkoxy group,
Acyloxy group, trialkylsilyloxy group,
Indicates an alkylthio group or an acylamino group, A
represents an alkylidene group optionally substituted with a trifluoromethyl group. ), R 2 is an alkyl group, alkenyl group, aralkyl group, aryl group, or R 5 -B- group (wherein R 5 is a hydroxyl group, an alkoxy group, an acyloxy group, a trialkylsilyloxy group, a carboxyl group, an alkoxy represents a carbonyl group, aralkyloxycarbonyl group, alkylthio group or acylamino group, B represents an alkylene group), R 3 represents a protecting group for the carboxyl group, X represents an oxygen atom or a sulfur atom, and Y represents a It represents an oxygen atom, a sulfur atom, a methylene group or an alkyl-substituted methylene group, and the R 2 -Y- group may represent a methyl group. ] is reacted with a trialkyl phosphite or triamide phosphite having the general formula (R 4 ) 3 P (wherein R 4 represents an alkoxy group or a dialkylamino group). general formula (In the formula, R 1 , R 2 , R 3 , R 4 , X and Y have the same meanings as described above.) Producing a phosphorus-ylide compound having the following formula, isolating it, and then heating it. A general formula characterized by (In the formula, R 1 , R 2 , R 3 and Y have the same meanings as described above.) A method for producing a penem-3-carboxylic acid derivative having the following formula. 3 General formula [In the formula, R 1 is a hydrogen atom, an alkyl group, or
R 4 A- group (wherein R 4 is a hydroxyl group, an alkoxy group,
Acyloxy group, trialkylsilyloxy group,
Indicates an alkylthio group or an acylamino group, A
represents an alkylidene group optionally substituted with a trifluoromethyl group. ), R 2 is an alkyl group, alkenyl group, aralkyl group, aryl group, or R 5 -B- group (wherein R 5 is a hydroxyl group, an alkoxy group, an acyloxy group, a trialkylsilyloxy group, a carboxyl group, an alkoxy represents a carbonyl group, aralkyloxycarbonyl group, alkylthio group or acylamino group, B represents an alkylene group), R 3 represents a protecting group for the carboxyl group, X represents an oxygen atom or a sulfur atom, and Y represents a represents an oxygen atom, a sulfur atom, a methylene group or an alkyl-substituted methylene group, and the R 2 -Y- group may represent a methyl group; R 4
represents an alkoxy group or a dialkylamino group. ] A general formula characterized by heating a phosphorus-ylide compound having (In the formula, R 1 , R 2 , R 3 and Y have the same meanings as described above.) A method for producing a penem-3-carboxylic acid derivative having the following formula.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8498180A JPS579784A (en) | 1980-06-23 | 1980-06-23 | Production of penem-3-carboxylic derivative |
FR8111191A FR2483924A1 (en) | 1980-06-06 | 1981-06-05 | PENEME-3-CARBOXYLIC ACID DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USE THEREOF |
ES502828A ES8300769A1 (en) | 1980-06-06 | 1981-06-05 | Penem-3-carboxylic acid derivatives |
NL8102736A NL8102736A (en) | 1980-06-06 | 1981-06-05 | PENEM-3-CARBONIC ACID COMPOUNDS AND THEIR PREPARATION. |
US06/271,010 US4395418A (en) | 1980-06-06 | 1981-06-05 | Penem-3-carboxylic acid derivatives |
DE19813122523 DE3122523A1 (en) | 1980-06-06 | 1981-06-05 | PENEM-3-CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THE SAME |
CH3723/81A CH651037A5 (en) | 1980-06-06 | 1981-06-05 | PENEM-3-CARBONIC ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. |
IT67783/81A IT1144602B (en) | 1980-06-06 | 1981-06-08 | DERIVATIVES OF PENICIL 3 CARBOXYLIC ACID AND PROCEDURE FOR THEIR PREPARATION |
GB8117447A GB2078220B (en) | 1980-06-06 | 1981-06-08 | Penem-3-carboxylic acid derivatives and their preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8498180A JPS579784A (en) | 1980-06-23 | 1980-06-23 | Production of penem-3-carboxylic derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS579784A JPS579784A (en) | 1982-01-19 |
JPH0316357B2 true JPH0316357B2 (en) | 1991-03-05 |
Family
ID=13845783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8498180A Granted JPS579784A (en) | 1980-06-06 | 1980-06-23 | Production of penem-3-carboxylic derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS579784A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4347183A (en) * | 1981-02-02 | 1982-08-31 | Schering Corporation | Process for the synthesis of penems and carbapenems |
KR900006449B1 (en) * | 1982-08-24 | 1990-08-31 | 상꾜 가부시끼가이샤 | Process for the preparation of azetidinone derivatives |
JPS60188030A (en) * | 1984-03-09 | 1985-09-25 | Riichi Nakagawa | Preparation of frozen "sushi" |
-
1980
- 1980-06-23 JP JP8498180A patent/JPS579784A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS579784A (en) | 1982-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0058317B1 (en) | Process for the preparation of 2-penem compounds | |
EP0037080B1 (en) | 4-(3-carboxy-2-oxopropyl)-azetidino-2-ones and process for their preparation | |
KR910002098B1 (en) | Process for penem compounds | |
NZ192542A (en) | 2-alkylthio-penem compounds and pharmaceutical compositions | |
JPH0653743B2 (en) | Method for producing β-lactam compound | |
US4584133A (en) | Process for the production of penems | |
WO1997041098A1 (en) | Azetidinone derivatives for the treatment of atherosclerosis | |
JPH0372630B2 (en) | ||
EP0110280B1 (en) | Process for the production of penem compounds | |
US5424422A (en) | Beta-lactams and their production | |
EP0026816A1 (en) | Intermediates for the preparation of thienamycin and process for preparing intermediates | |
JPH0316357B2 (en) | ||
JPS6254427B2 (en) | ||
DK153553B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF 2- (FLUORAL CHYLTHIO) -SUBSTITUTED PENEM COMPOUNDS | |
KR940008748B1 (en) | Process for preparing heterocyclic compounds | |
JPWO2004089954A1 (en) | New carbapenem compounds | |
JP2510860B2 (en) | Process for producing new β-lactam derivative | |
US5578722A (en) | Process for preparing carbapenem compounds | |
US4772683A (en) | High percentage beta-yield synthesis of carbapenem intermediates | |
KR20050075392A (en) | Novel intermediate for carbapenem compound for oral administration and process for producing the same | |
US4769451A (en) | Synthesis of carbapenems using n-substituted azetidinones | |
JPH06104672B2 (en) | Penems production method | |
US4610820A (en) | Process for the preparation of thienamycin and intermediates | |
JPH0129185B2 (en) | ||
US4895940A (en) | Process for the preparation of penems |